Related Experiment Videos
Cefotetan: a perspective for the surgical patient
1Department of Surgery, University of New Mexico School of Medicine, Albuquerque 87131.
American Journal of Surgery
|May 31, 1988
Summary
Cefotetan demonstrates comparable effectiveness to cefoxitin for surgical prophylaxis and mild-to-moderate infections. Its longer half-life allows for less frequent dosing, suggesting potential advantages in antibiotic therapy.
Area of Science:
- Infectious Diseases
- Pharmacology
- Surgical Care
Background:
- Surgical prophylaxis and polymicrobial infections require effective antibiotic strategies.
- Cefotetan and cefoxitin are commonly used cephalosporins.
- Understanding comparative effectiveness and dosing advantages is crucial.
Purpose of the Study:
- To compare the clinical effectiveness of cefotetan versus cefoxitin.
- To evaluate cefotetan's utility in surgical prophylaxis and polymicrobial infections.
- To explore the implications of cefotetan's prolonged serum elimination half-life.
Main Methods:
- Clinical data analysis comparing cefotetan and cefoxitin.
- Evaluation of treatment outcomes in surgical prophylaxis.
- Assessment of efficacy in mild-to-moderate polymicrobial infections.
Main Results:
- Cefotetan shows comparable clinical effectiveness to cefoxitin.
- Cefotetan's longer serum elimination half-life permits less frequent administration.
- Initial clinical experience with cefotetan is favorable.
Conclusions:
- Cefotetan is a viable alternative to cefoxitin in specific clinical settings.
- The extended half-life of cefotetan offers potential for improved dosing convenience.
- Further research is needed for seriously ill patients and specific risks.